Syntopa develops precision biologics using our proprietary methods and the latest technologies from Ag Tech and Synthetic Biology.
Syntopa has raised $575K in total funding. The most recent round was Pre-Seed. The last funding was announced in January 2024.
Syntopa's investors include Ponderosa Ventures.
Syntopa is headquartered in Alameda, United States.
Syntopa develops precision biologics using our proprietary methods and the latest technologies from Ag Tech and Synthetic Biology.
Syntopa is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Syntopa — Funding & Investors." VCBacked, January 1, 2024, https://www.vcbacked.co/company/syntopa. Accessed August 15, 2026.
VCBacked. (2024). Syntopa — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/syntopa
{{cite web |title=Syntopa — Funding & Investors |url=https://www.vcbacked.co/company/syntopa |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated